Skip to main content

Year: 2023

Hudson Technologies to Host Conference Call to Discuss Third Quarter 2023 Results

WOODCLIFF LAKE, N.J., Oct. 18, 2023 (GLOBE NEWSWIRE) — Hudson Technologies, Inc. (NASDAQ: HDSN) will host a conference call and webcast on Wednesday, November 1, 2023 at 5:00 p.m. Eastern Time to discuss the Company’s third quarter 2023 results. To access the live webcast, log onto the Hudson Technologies website at www.hudsontech.com, and click on “Investor Relations”. To participate in the call by phone, dial (888) 506-0062 approximately five minutes prior to the scheduled start time. International callers please dial (973) 528-0011. Callers should use entry code: 980505 A replay of the teleconference will be available until December 1, 2023 and may be accessed by dialing (877) 481-4010. International callers may dial (919) 882-2331. Callers should use conference ID: 49295. About Hudson Technologies          Hudson Technologies,...

Continue reading

LM Funding America, Inc. Provides Quarterly Operational and Bitcoin Mining Update for Three Months Ended September 30, 2023

Reports Increases in Bitcoin Mined, Bitcoin Sold and New Mining Machines TAMPA, Oct. 18, 2023 (GLOBE NEWSWIRE) — LM Funding America, Inc. (NASDAQ:LMFA) (“LM Funding” or the “Company”), a cryptocurrency mining and technology-based specialty finance company, today provided a preliminary, unaudited Bitcoin mining update for the nine months ended September 30, 2023.  Metrics *   Three Months March 31, 2023   Three Months June 30, 2023 Three Months September 30, 2023 Nine Months September 30, 2023Bitcoin Mined 91.7 106.6 117.1 315.4Bitcoin Sold (64.9) (111.0) (106.1) (282.0)Bitcoin Purchased 2.0 – – 2.0Fees (0.1) (0.1) – (0.2)         Bitcoin Holdings 83.6 79.1 90.1 90.1         Approximate Miners Deployed at Quarter End 3,700 5,230 5,950  Approximate Deployed Hash Rate at Quarter End...

Continue reading

Hillman Sets Third Quarter 2023 Earnings Release and Results Presentation Date

CINCINNATI, Oct. 18, 2023 (GLOBE NEWSWIRE) — Hillman Solutions Corp. (Nasdaq: HLMN) (“Hillman”), a leading provider of hardware products and merchandising solutions, plans to host a conference call to discuss its results for the thirteen and thirty-nine weeks ended September 30, 2023 on Wednesday, November 8, 2023 at 8:30 a.m. Eastern Time. Hillman will issue its earnings release on the same day prior to the results presentation. Chairman, President, and Chief Executive Officer Doug Cahill, Chief Financial Officer Rocky Kraft, and Chief Operating Officer Jon Michael Adinolfi will host the results presentation. Results Presentation Details: Date: Wednesday, November 8, 2023 Time: 8:30 a.m. Eastern Time Listen-Only Webcast: https://edge.media-server.com/mmc/p/vrzpqs3k  Research analysts wishing to participate in the call’s live question...

Continue reading

IMUNON Announces First Patient enrolled in Phase 1/2 Clinical Trial of IMNN-001 in Combination with bevacizumab in Advanced Ovarian Cancer

The MRD trial will evaluate the effect of this treatment combination on minimal residual disease. LAWRENCEVILLE, N.J., Oct. 18, 2023 (GLOBE NEWSWIRE) — IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing non-viral DNA-mediated immunotherapy and next-generation vaccines, announces that the first patient in a Phase 1/2 clinical trial evaluating IMUNON’s IMNN-001 in combination with bevacizumab in advanced ovarian cancer has begun treatment. IMNN-001 is a DNA-based interleukin-12 (IL-12) immunotherapy currently in Phase 2 clinical development for the localized treatment of advanced ovarian cancer (the OVATION 2 Study). This Phase 1/2 trial is expected to enroll 50 patients with Stage III/IV advanced ovarian cancer. Patients undergoing frontline neoadjuvant therapy will be randomized 1:1 to...

Continue reading

FDA Grants SeaStar Medical’s Selective Cytopheretic Device Breakthrough Device Designation for Hepatorenal Syndrome

DENVER, Oct. 18, 2023 (GLOBE NEWSWIRE) — SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces receipt of U.S. Food and Drug Administration (FDA) Breakthrough Device Designation for its patented, first-in-class, cell-directed Selective Cytopheretic Device (SCD) for use with patients in the hospital intensive care unit (ICU) with acute kidney injury (AKI) and acute on chronic liver failure. This is the third Breakthrough Device Designation granted by the FDA to SeaStar Medical for the SCD device, and is expected to expedite the clinical development and regulatory review of the SCD for use in this patient population. “Hepatorenal syndrome is characterized by an abrupt deterioration of kidney function,...

Continue reading

Barfresh Highlights a Number of Recent Wins Within the Education Channel

Expansion Includes Seven New School Districts with Over 1,000 New School Locations Company Secures One of The Top Five Largest School Districts in the United States LOS ANGELES, Oct. 18, 2023 (GLOBE NEWSWIRE) — Barfresh Food Group Inc. (the “Company” or “Barfresh”) (Nasdaq: BRFH), a provider of frozen, ready-to-blend and ready-to-drink beverages, has continued to expand its presence within the education channel and announced today a number of recent large wins within the education channel. The Company recently secured a number of additional new school districts, including seven serving over 1,000 new school locations. These districts, representing a collective population of over 750,000 students, will serve the Company’s ready-to-drink smoothie products. Additionally, one of the seven new districts is in the top five largest school...

Continue reading

DatChat Receives Notice of Allowance for its Patent Application “Technology Platform for Providing Secure Group-Based Digital Access to Sets of Digital Assets”

Technology will Power Its New Interactive “Family Museum” Digital Archive Platform New Brunswick, NJ, Oct. 18, 2023 (GLOBE NEWSWIRE) — DatChat (Nasdaq: DATS), a secure messaging, social media, and metaverse company, today announced that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for patent application No. 18/451,449 titled, “Technology platform for providing secure group-based access to sets of digital assets.” This patent enables the preservation of data, including storage, sharing, and secure control of data on social media technology platforms and digital archives. “This patent is possibly the most important of the nine we now have in our intellectual property portfolio.” said DatChat CEO, Darin Myman.” “This patent will serve to protect the core technology that will power...

Continue reading

GeneType Predicting Risk of Pancreatic Cancer: Major Breakthrough in Early Detection and Treatment

MELBOURNE, Australia, Oct. 18, 2023 (GLOBE NEWSWIRE) — Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and serious disease, is pleased to announce the publication of a peer-reviewed research paper validating geneType’s Pancreatic Cancer risk assessment test. Highlights:Pancreatic cancer has a very high mortality rate, approximately 76%1 of those diagnosed will die within 1 year. The five-year survival rate is only 9%2. GeneType’s Pancreatic Cancer risk assessment test showed a nearly 50% improvement to the traditional clinical risk score in identifying patients at a high risk of developing pancreatic cancer. GeneType for Pancreatic Cancer will lead to a significant improvement to the number of pancreatic cancers being discovered earlier. When...

Continue reading

ReWalk Robotics Exhibits at the GITEX GLOBAL Intelligent Connectivity / AI Pavilion

A key theme for the event is that 2023 marks “The Year to imagine AI in Everything”. MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, Oct. 18, 2023 (GLOBE NEWSWIRE) — ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or “the Company”), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, today announced that ReWalk will be presenting the ReWalk Exoskeleton to the GITEX GLOBAL audience in Dubai this week from Oct 16-20, 2023. ReWalk is demonstrating the sixth generation ReWalk system with a ReWalk user who is walking throughout the AI Pavilion meeting with the audience this week. CEO Larry Jasinski stated: “We find this an ideal event to demonstrate our current product design while we advance the addition of AI to make our...

Continue reading

Erdene Provides Update on Strategic Alliance With Mongolian Mining Corporation

HALIFAX, Nova Scotia, Oct. 18, 2023 (GLOBE NEWSWIRE) — Erdene Resource Development Corp. (TSX:ERD; MSE:ERDN) (“Erdene” or the “Company“) is pleased to provide an update on its Strategic Alliance with Mongolian Mining Corporation (“MMC”) for the development of its high-grade, open-pit Bayan Khundii Gold Project (“Bayan Khundii”, “BK” or “Project”) in southwestern Mongolia. Strategic Alliance with MMC On January 10, 2023, Erdene executed a Strategic Alliance Agreement (“SAA”) with MMC to develop the Bayan Khundii Gold Project (see press release here). Highlights of the SAA include:MMC is Mongolia’s largest internationally traded mining company, listed on the main board of the Hong Kong Stock Exchange (HKEx: 975). MMC to invest US$40 million for a 50% equity interest in Erdene’s Mongolian subsidiary,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.